R10056 |
Tubastatin-A |
Tubastatin A is a potent and selective HDAC6 inhibitor withIC50 o
|
R10179 |
4SC201 |
Resminostat dose-dependently and selectively inhibits HDAC1/3/6 with IC50 of 42.
|
R10191 |
Tacedinaline (N-acetyldinaline; CI-994; Goe-5549) |
CI994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.
|
R10239 |
Tubastain A |
Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a c
|
R10422 |
BRD73954 |
BRD73954 is a potent and selective HDAC inhibitor with IC50 of 36 nM and 120 nM
|
R10424 |
JNJ26481585; Quisinostat |
Quisinostat is an orally available, potent, hydroxamate, pan-HDACi with broad ac
|
R10572 |
Belinostat;PXD101 |
Belinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM in a cell-free
|
R10617 |
Pracinostat (SB939) |
Pracinostat (SB939) is a potent pan-HDAC inhibitor with IC50 of 40-140 nM with e
|
R10669 |
TMP269 |
TMP269 is a potent, selective class IIa HDAC inhibitor with IC50 of 157 nM, 97 n
|
R10671 |
NexturastatA |
Nexturastat A is a potent and selective HDAC6 inhibitor with IC50 of 5 nM, >1
|
R10697 |
HDAC-IN-7 (Chidamide impurity) |
Chidamide(CS055; HBI-8000) is a class I HDAC inhibitor with IC50s of 95/160/67/7
|
R10732 |
MC1568 |
MC1568 is a selective HDAC inhibitor for maize HD1-A with IC50 of 100 nM in a ce
|
R10759 |
CAY10683;Santacruzamate A |
Santacruzamate A (CAY10683) is a potent and selective HDAC inhibitor with IC50 o
|
R10777 |
bml-210 |
BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been ch
|
R10778 |
Pimelic diphenylamide 106; TC-H106 |
Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (HD
|
R10779 |
UF010 |
UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μ
|
R10886 |
Domatinostat (4SC-202 free base) |
Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50
|
R11453 |
JNJ26854165;Quisinostat 2HCl |
Quisinostat (JNJ-26481585) 2HCl is a novel second-generation HDAC inhibitor with
|
R11501 |
Panobinostat (LBH589; NVP-LBH589) |
Panobinostat (LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM
|
R11530 |
RG2833 (RGFP109) |
RG2833 (RGFP109) is a brain-penetrant HDAC inhibitor with IC50 of 60 nM and 50 n
|
R2032483 |
PCI-24781 |
Abexinostat (CRA 024781) is a novel pan-HDAC inhibitor mostly targeting HDAC1 wi
|